| Structure Identification: |
| Chinese Traditional & Herbal Drugs,2015 , 46 (12) :1742-1748. | | Chemical constituents of Aganosma marginata[Reference: WebLink] | To investigate the chemical constituents from Aganosma marginata and to provide the material basis for the quality control.
METHODS AND RESULTS:
The chemical constituents were separated and purified by silica gel Sephadex LH-20,MCI.Their structures were determined by physicochemical properties and spectral data analyses. Twenty three compounds were isolated from A.marginata and identified as:periseoside C(1),3-O-β-D-glucopyranosyl-3β,15α-dihydroxypregn-5-en-20-one(2),3β,20α-dihydroxy-5-en-pregane(3),28-methylstigmast-5-en-3-ol(4),29-Norcycloart-23-ene-3,25-diol(5),29-norcycloartan-3-ol(6),geniposidic acid(7),syringaresinol(8),syringaresinol-4,4'-O-bis-β-D-glucopyranoside(9),syringic acid 4-O-β-D-glucopyranoside(10),salicylic acid(11),scopoletin(12),azelaic acid(13),3-O-[β-D-xylopyranosyl]-(l→4)-β-D-allopyranoside-14-hydroxycard-20(22)-enolide(14),bis(2-ethylhexyl) phthalate(15),kaempferol-3-O-α-L-rharnnopyranosyl-(1→4)-α-L-glucopyranoside(16),kaempferol-3-O-α-Lglucopyranoside-(1→2)-β-D-glucopyranoside(17),kaempferol-3-O-α-L-rhamnopyranosyl-(1→4)-[α-L-rhamnopyranosyl(1→4)]-β-D-glucopyranoside(18),kaempferol-3-O-α-L-rhamnopyranosyl-(1→4)-[β-D-glucopyranosyl-(1→4)]-β-D-glucopyranoside(19),hexacosanoicacid 1-carbonate(20),5,8,12-trihydroxy-9-octadecenoic acid(21),(2S,3S,4R)-phytosphingosine(22),and nebularine(23).
CONCLUSIONS:
All the compounds are obtained from plants of Aganosma G.Don for the first time. |
|
Cell. 2018 Jan 11;172(1-2):249-261.e12. doi: 10.1016/j.cell.2017.12.019.IF=36.216(2019)
Cell Metab. 2020 Mar 3;31(3):534-548.e5. doi: 10.1016/j.cmet.2020.01.002.IF=22.415(2019)
Mol Cell. 2017 Nov 16;68(4):673-685.e6. doi: 10.1016/j.molcel.2017.10.022.IF=14.548(2019)
ACS Nano. 2018 Apr 24;12(4): 3385-3396. doi: 10.1021/acsnano.7b08969.IF=13.903(2019)
Nature Plants. 2016 Dec 22;3: 16206. doi: 10.1038/nplants.2016.205.IF=13.297(2019)
Sci Adv. 2018 Oct 24;4(10): eaat6994. doi: 10.1126/sciadv.aat6994.IF=12.804(2019)